Tilray (NASDAQ:TLRY) Trading 0.7% Higher – Should You Buy?

Shares of Tilray Inc (NASDAQ:TLRY) were up 0.7% on Tuesday . The company traded as high as $1.45 and last traded at $1.41. Approximately 11,783,609 shares traded hands during trading, a decline of 54% from the average daily volume of 25,383,082 shares. The stock had previously closed at $1.40.

Analyst Ratings Changes

Separately, Roth Mkm reduced their price objective on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th.

Tilray Trading Down 4.2 %

The stock has a market cap of $1.25 billion, a PE ratio of -5.17 and a beta of 2.14. The company has a 50 day moving average of $1.66 and a two-hundred day moving average of $1.78. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The firm had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same quarter in the previous year, the company posted ($0.10) EPS. The company’s revenue was up 13.0% compared to the same quarter last year. Sell-side analysts anticipate that Tilray Inc will post -0.14 earnings per share for the current fiscal year.

Institutional Trading of Tilray

Hedge funds have recently made changes to their positions in the business. Ferguson Wellman Capital Management Inc. purchased a new position in shares of Tilray in the 3rd quarter valued at about $26,000. HBK Sorce Advisory LLC purchased a new stake in shares of Tilray in the 1st quarter valued at approximately $37,000. Prospect Financial Services LLC acquired a new stake in shares of Tilray in the 2nd quarter valued at $26,000. Signature Estate & Investment Advisors LLC purchased a new stake in shares of Tilray during the 2nd quarter worth $29,000. Finally, Jeppson Wealth Management LLC acquired a new position in shares of Tilray during the second quarter worth $33,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.